Recro Pharma (REPH) Misses Q1 EPS by 1c

Recro Pharma (NASDAQ: REPH) reported Q1 EPS of ($0.53), $0.01 worse than the analyst estimate of ($0.52).

For earnings history and earnings-related data on Recro Pharma (REPH) click here.

You May Also Be Interested In

• H&R Block (HRB) Tops Q4 EPS by 7c, Offers Guidance
• Black Rock Coffee Bar, Inc. (BRCB) Misses Q2 EPS by 1c
• Aardvark Therapeutics (AARD) Tops Q2 EPS by 21c